Filing Details

Accession Number:
0000905148-17-000702
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-07-28 16:29:23
Reporting Period:
2017-06-19
Filing Date:
2017-07-28
Accepted Time:
2017-07-28 16:29:23
Original Submission Date:
2017-06-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1300699 Athenex Inc. ATNX Pharmaceutical Preparations (2834) 431985966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1708965 Rudolf Kwan C/O Athenex, Inc., 1001 Main Street
Suite 600
Buffalo NY 14203
Evp, Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-19 49,700 $11.00 49,700 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares of Common Stock ("Shares") were inadvertently omitted from the Reporting Person's Form 4 filed June 21, 2017.
  2. These Shares were purchased in the Issuer's initial public offering, which closed on June 19, 2017.